ICUCW SeaStar Medical Holding Corporation - Warrant
$0,02
Prezzo · Ago 19, 2026
Fondamentali al Ago 12, 2026
Intervallo 52 sett.
$0–$0
56% of range
Rating Analisti
—
Prezzo Obiettivo
—
P/E (TTM)
—
ROE
-176.6%
Margine di Profitto Netto
-984.6%
ICUCW Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.02
Capitalizzazione di Mercato
—
P/E (TTM)
—
EPS (TTM)
$-6.63
Ricavi (TTM)
$1M
Rendimento div.
—
ROE
-176.6%
D/E Debito/Patrimonio
0.1
Intervallo 52 sett.
$0 – $0
ICUCW Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$1M
2023-12-31
→
2025-12-31
EPS
$-6.63
2021-12-31
→
2024-12-31
Flusso di cassa libero
—
Margini
-984.6%
2025-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ICUCW
Mediana dei peer
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ICUCW
Mediana dei peer
Gross Margin (Margine lordo)
95.7%
—
Operating Margin (Margine Operativo)
-986.6%
—
Net Profit Margin (Margine di Profitto Netto)
-984.6%
—
ROA
-129.2%
—
ROE
-176.6%
—
ROIC
-111.3%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ICUCW
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
0.1
—
Current Ratio (Rapporto corrente)
3.6
—
Quick Ratio
3.3
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ICUCW
Mediana dei peer
Revenue YoY (Ricavi YoY)
814.1%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ICUCW
Mediana dei peer
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 18
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1M | $135.0K | $0 | |
| Cost of Revenue | $53.0K | $0 | $0 | |
| Gross Profit | $1M | $135.0K | $0 | |
| R&D Expense | $8M | $9M | $6M | |
| SG&A Expense | $6M | $9M | $8M | |
| Operating Expenses | $13M | $18M | $14M | |
| Operating Income | $-12M | $-18M | $-14M | |
| Interest Expense | · | $244.0K | $1M | |
| Interest Income | $325.0K | $101.0K | $0 | |
| Other Non-op | $28.0K | $-7M | $-12M | |
| Pretax Income | $-12M | $-25M | $-26M | |
| Income Tax | $3.0K | $3.0K | $0 | |
| Net Income | $-12M | $-25M | $-26M | |
| EPS (Basic) | $-5.86 | $-66.33 | $-30.26 | |
| EPS (Diluted) | · | $-6.63 | $-30.26 | |
| Shares (Basic) | 2,073,087 | 374,356 | 866,813 | |
| Shares (Diluted) | · | 3,743,554 | 866,813 | |
| EBITDA | $-12M | · | · |
Stato Patrimoniale 20
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $12M | $2M | $176.0K | |
| Receivables | $237.0K | $112.0K | $0 | |
| Inventory | $66.0K | $0 | · | |
| Prepaid Expense | $1M | $2M | $2M | |
| Current Assets | $14M | $4M | $2M | |
| Other Non-current Assets | $578.0K | $892.0K | · | |
| Total Assets | $14M | $5M | $4M | |
| Accounts Payable | $948.0K | $3M | $4M | |
| Accrued Liabilities | $2M | $3M | $2M | |
| Short-term Debt | $525.0K | $574.0K | $565.0K | |
| Current Liabilities | $4M | $7M | $13M | |
| Total Liabilities | $4M | $7M | $17M | |
| Long-term Debt | · | · | $4M | |
| Total Debt | $525.0K | · | · | |
| Common Stock | $4.0K | $2.0K | $1.0K | |
| Paid-in Capital | $162M | $137M | $101M | |
| Retained Earnings | $-152M | $-140M | $-115M | |
| Stockholders' Equity | $10M | $-2M | $-14M | |
| Liabilities + Equity | $14M | $5M | $4M | |
| Shares Outstanding | 3,844,613 | 650,639 | 2,016,045 |
Flusso di cassa 7
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $624.0K | $887.0K | $2M | |
| Operating Cash Flow | $-14M | $-16M | $-10M | |
| Debt Issued | · | $1M | · | |
| Stock Issued | $16M | $17M | $5M | |
| Net Stock Activity | $16M | · | · | |
| Financing Cash Flow | $24M | $18M | $10M | |
| Net Change in Cash | $10M | $2M | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 95.7% | · | · | |
| Operating Margin | -986.6% | · | · | |
| Net Margin | -984.6% | · | · | |
| Pretax Margin | -984.4% | · | · | |
| EBITDA Margin | -986.6% | · | · | |
| ROA | -129.2% | · | · | |
| ROE | -176.6% | · | · | |
| ROIC | -111.3% | · | · |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.6 | · | · | |
| Quick Ratio | 3.3 | · | · | |
| Debt / Equity | 0.1 | · | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | |
| Inventory Turnover | 1.6 | · | · | |
| Receivables Turnover | 7.1 | · | · |
Tassi di Crescita 1
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 814.1% | · | · |
Valutazione (TTM) 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1M | $135.0K | $0 | |
| Net Income TTM | $-12M | $-25M | $-26M |
Conto Economico 18
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $615.0K | $420.0K | $183.0K | $338.0K | $293.0K | $67.0K | $68.0K | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $54.0K | $12.0K | $14.0K | $27.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Gross Profit | $561.0K | $408.0K | $169.0K | $311.0K | $293.0K | $67.0K | $68.0K | $0 | $0 | · | · | |
| R&D Expense | $3M | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $2M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $3M | $4M | $2M | $4M | $5M | $5M | $5M | $4M | $3M | $3M | |
| Operating Income | $-4M | $-3M | $-4M | $-2M | $-4M | $-5M | $-4M | $-5M | $-4M | $-3M | $-3M | |
| Interest Expense | · | · | · | $9.0K | $11.0K | · | $272.0K | $82.0K | $143.0K | $199.0K | $224.0K | |
| Interest Income | $69.0K | $125.0K | $107.0K | $45.0K | $48.0K | $18.0K | $58.0K | $25.0K | $0 | $0 | $0 | |
| Other Non-op | $61.0K | $114.0K | $107.0K | $-246.0K | $53.0K | $348.0K | $-22.0K | $1M | $-9M | $-7M | $-4M | |
| Pretax Income | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-3M | $-13M | $-9M | $-7M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $0 | $-5.0K | $0 | |
| Net Income | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-3M | $-13M | $-9M | $-7M | |
| EPS (Basic) | $-0.91 | $-5.11 | $-0.13 | $-1.77 | $-0.44 | $-59.47 | $-1.10 | $-1.03 | $-4.73 | $-16.60 | $-9.02 | |
| EPS (Diluted) | · | · | · | $-0.18 | $-0.44 | · | $-1.10 | $-1.03 | $-4.73 | $-16.60 | $-9.02 | |
| Shares (Basic) | 4,084,283 | -44,267,762 | 26,393,400 | 1,132,952 | 8,617,932 | -9,551,540 | 4,086,871 | 3,154,782 | 2,684,243 | -13,558,293 | 801,939 | |
| Shares (Diluted) | · | · | · | 11,329,517 | 8,617,932 | · | 4,086,871 | 3,154,782 | 2,684,243 | -13,558,293 | 801,939 | |
| EBITDA | $-4M | · | $-4M | $-2M | $-4M | · | $-4M | $-5M | $-4M | · | $-3M |
Stato Patrimoniale 20
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $12M | $14M | $6M | $5M | $2M | $2M | $1M | $5M | $176.0K | $73.0K | |
| Receivables | $208.0K | $237.0K | $221.0K | $217.0K | $110.0K | $112.0K | $68.0K | · | · | $0 | · | |
| Inventory | $77.0K | $66.0K | $83.0K | $77.0K | $44.0K | $0 | $0 | · | · | · | · | |
| Prepaid Expense | $984.0K | $1M | $807.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | |
| Current Assets | $8M | $14M | $15M | $8M | $7M | $4M | $4M | $2M | $7M | $2M | $2M | |
| Other Non-current Assets | $421.0K | $578.0K | $656.0K | · | · | $892.0K | · | · | · | · | · | |
| Total Assets | $9M | $14M | $16M | $8M | $8M | $5M | $5M | $3M | $8M | $4M | $2M | |
| Accounts Payable | $750.0K | $948.0K | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | |
| Accrued Liabilities | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | |
| Short-term Debt | $134.0K | $525.0K | $0 | $0 | $363.0K | $574.0K | $0 | $3M | $357.0K | $565.0K | $0 | |
| Current Liabilities | $4M | $4M | $4M | $5M | $7M | $7M | $7M | $10M | $10M | $13M | $12M | |
| Total Liabilities | $4M | $4M | $4M | $5M | $7M | $7M | $7M | $10M | $12M | $17M | $18M | |
| Long-term Debt | · | · | · | · | · | · | $0 | $0 | $1M | $4M | $6M | |
| Total Debt | $134.0K | · | $0 | $0 | $363.0K | · | $0 | $3M | $357.0K | · | $0 | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $8.0K | $1.0K | $3.0K | |
| Paid-in Capital | $163M | $162M | $160M | $149M | $144M | $137M | $133M | $124M | $123M | $101M | $100M | |
| Retained Earnings | $-159M | $-152M | $-149M | $-145M | $-143M | $-140M | $-135M | $-131M | $-127M | $-115M | $-116M | |
| Stockholders' Equity | $4M | $10M | $11M | $3M | $565.0K | $-2M | $-2M | $-7M | $-4M | $-14M | $-16M | |
| Liabilities + Equity | $9M | $14M | $16M | $8M | $8M | $5M | $5M | $3M | $8M | $4M | $2M | |
| Shares Outstanding | 4,259,842 | 3,844,613 | 34,096,420 | 17,343,269 | 9,257,763 | 650,639 | 4,214,399 | 1,904,611 | 75,419,458 | 2,016,045 | 27,201,087 |
Flusso di cassa 8
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $-99.0K | $70.0K | $290.0K | $97.0K | $167.0K | $212.0K | $200.0K | $41.0K | $434.0K | $386.0K | $484.0K | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-3M | $-3M | $-5M | $-5M | $-3M | $-3M | $-4M | $-1M | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $1M | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $1M | · | · | |
| Stock Issued | $810.0K | $2M | $9M | $4M | $2M | $4M | $9M | $-51.0K | $5M | $3M | $120.0K | |
| Net Stock Activity | · | · | · | · | $2M | · | · | · | $5M | · | · | |
| Financing Cash Flow | $605.0K | $2M | $11M | $4M | $6M | $4M | $6M | $-1M | $8M | $5M | $1M | |
| Net Change in Cash | $-2M | $-2M | $7M | $1M | · | $-263.0K | · | · | · | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 91.2% | · | 92.3% | 92.0% | 100.0% | · | 100.0% | · | · | · | · | |
| Operating Margin | -616.4% | · | -1955.7% | -519.5% | -1304.4% | · | -6552.9% | · | · | · | · | |
| Net Margin | -606.5% | · | -1897.3% | -592.3% | -1287.4% | · | -6585.3% | · | · | · | · | |
| Pretax Margin | -606.5% | · | -1897.3% | -592.3% | -1286.3% | · | -6585.3% | · | · | · | · | |
| EBITDA Margin | -616.4% | · | -1955.7% | -519.5% | -1304.4% | · | -6552.9% | · | · | · | · | |
| ROA | -43.8% | · | -34.5% | -33.8% | -49.2% | · | -131.1% | -111.6% | -228.2% | · | -13.6% | |
| ROE | -97.7% | · | -73.8% | 112.5% | 193.0% | · | 49.9% | 35.3% | 165.4% | · | 59.9% | |
| ROIC | -85.6% | · | -31.2% | -52.6% | -412.2% | · | 217.2% | 124.3% | 96.0% | · | 18.5% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 3.7 | 1.5 | 1.0 | · | 0.5 | 0.2 | 0.7 | · | 0.2 | |
| Quick Ratio | 1.6 | · | 3.4 | 1.3 | 0.8 | · | 0.3 | 0.1 | 0.5 | · | 0.0 | |
| Debt / Equity | 0.0 | · | 0.0 | 0.0 | 0.6 | · | 0.0 | -0.5 | -0.1 | · | 0.0 | |
| Interest Coverage | · | · | · | -195.1 | -347.5 | · | -16.4 | -56.9 | -27.6 | · | -13.1 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.7 | · | 0.3 | 0.7 | 0.0 | · | · | · | · | · | · | |
| Receivables Turnover | 2.9 | · | 1.3 | 3.1 | 5.3 | · | 2.0 | · | · | · | · |
Valutazione (TTM) 11
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | · | $882.0K | $699.0K | $361.0K | · | $68.0K | · | · | · | · | |
| Net Income TTM | $-13M | · | $-14M | $-13M | $-24M | · | $-28M | $-26M | $-29M | · | $-19M | |
| Market Cap | $126.9K | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $-7M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.1 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 1.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -4.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -9228.2% | · | · | · | · | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ricavi | $1M | $135.0K | $0 | — | — |
| Margine Lordo % | 95.7% | — | — | — | — |
| Margine Operativo % | -986.6% | — | — | — | — |
| Utile netto | $-12M | $-25M | $-26M | — | — |
| EPS Diluito | — | $-6.63 | $-30.26 | — | — |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.1 | — | — | — | — |
| Rapporto corrente | 3.6 | — | — | — | — |
| Quick Ratio | 3.3 | — | — | — | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 17 filer · $921K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 4 (+3 vs trimestre precedente) | 0 (-5 vs trimestre precedente) | 2 (+2 vs trimestre precedente) | 1 (0 vs trimestre precedente) | +111K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $899.884 | 245.200 | 97,68% | Azioni |
| ATW SPAC MANAGEMENT LLC | $6.645 | 245.200 | 0,72% | Azioni |
| GOLDMAN SACHS GROUP INC | $3.657 | 211.381 | 0,40% | Azioni |
| Linden Advisors LP | $3.511 | 218.073 | 0,38% | Azioni |
| LMR Partners LLP | $2.163 | 125.000 | 0,23% | Azioni |
| CLEAR STREET LLC | $929 | 46.690 | 0,10% | Azioni |
| Clear Street Group Inc. | $808 | 46.690 | 0,09% | Azioni |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $692 | 40.000 | 0,08% | Azioni |
| EQUITEC PROPRIETARY MARKETS, LLC | $618 | 35.700 | 0,07% | Azioni |
| Cruiser Capital Advisors, LLC | $562 | 32.473 | 0,06% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $539 | 36.179 | 0,06% | Azioni |
| TWO SIGMA SECURITIES, LLC | $421 | 24.322 | 0,05% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $389 | 22.500 | 0,04% | Opzione Call |
| StoneX Group Inc. | $208 | 11.086 | 0,02% | Azioni |
| WOLVERINE ASSET MANAGEMENT LLC | $192 | 11.081 | 0,02% | Azioni |
| UBS Group AG | $14 | 801 | 0,00% | Azioni |
| Virtu Financial LLC | $1 | 40.316 | 0,00% | Azioni |
Insider aziendali 6 insider · 2 dirigenti · 4 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric Schlorff | Chief Executive Officer | 01 Luglio 2026 A | 50.140 | 0 | 0 | $0 |
| Kevin Chung | Chief Medical Officer | 01 Luglio 2026 A | 28.021 | 0 | 0 | $0 |
| Bernadette N Vincent | Direttore | 01 Luglio 2026 A | 8.200 | 0 | 0 | $0 |
| Jennifer A Baird | Direttore | 01 Luglio 2026 A | 10.620 | 0 | 0 | $0 |
| John Neuman | Direttore | 01 Luglio 2026 A | 16.200 | 0 | 0 | $0 |
| Kenneth Van Heel | Direttore | 01 Luglio 2026 A | 11.940 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato